Umezawa R, Mizuma M, Nakagawa K, Yamamoto T, et al. Clinical impact of multimodal treatment including chemoradiotherapy, conversion surgery and postoperative chemotherapy for borderline resectable and unresectable locally advanced pancreatic cancer without disease progression after gemcitabine plus nab Pancreatology 2023 Jul 4:S1424-3903(23)01566-1. doi: 10.1016/j.pan.2023.
PMID: 37453848